CLADRIBINE for Secondary progressive multiple sclerosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 32 adverse event reports in the FDA FAERS database where CLADRIBINE was used for Secondary progressive multiple sclerosis.
Most Reported Side Effects for CLADRIBINE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 696 | 9.3% | 4 | 77 |
| Headache | 579 | 7.7% | 2 | 53 |
| Lymphocyte count decreased | 448 | 6.0% | 3 | 125 |
| Multiple sclerosis relapse | 404 | 5.4% | 2 | 151 |
| Nausea | 354 | 4.7% | 5 | 53 |
| Pneumonia | 318 | 4.2% | 35 | 121 |
| White blood cell count decreased | 311 | 4.1% | 3 | 64 |
| Urinary tract infection | 242 | 3.2% | 6 | 132 |
| Pyrexia | 207 | 2.8% | 20 | 115 |
| Multiple sclerosis | 206 | 2.7% | 4 | 60 |
| Off label use | 197 | 2.6% | 34 | 48 |
| Asthenia | 195 | 2.6% | 6 | 68 |
| Drug ineffective | 189 | 2.5% | 32 | 38 |
| Lymphopenia | 188 | 2.5% | 2 | 52 |
| Covid-19 | 179 | 2.4% | 15 | 72 |
Other Indications for CLADRIBINE
Multiple sclerosis (5,360)
Relapsing-remitting multiple sclerosis (581)
Hairy cell leukaemia (331)
Acute myeloid leukaemia (281)
Product used for unknown indication (162)
Relapsing multiple sclerosis (123)
Langerhans' cell histiocytosis (116)
Chronic lymphocytic leukaemia (38)
Rosai-dorfman syndrome (20)
Erdheim-chester disease (17)
Other Drugs Used for Secondary progressive multiple sclerosis
SIPONIMOD (2,265)
OCRELIZUMAB (1,273)
OFATUMUMAB (1,099)
FINGOLIMOD (351)
INTERFERON BETA-1B (146)
RITUXIMAB (131)
NATALIZUMAB (115)
DIMETHYL (96)
INTERFERON BETA-1A (89)
RABEPRAZOLE (86)